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Abstract: The use of herbomineral formulations in the healthcare sector has increased due to their high safety and better 
therapeutic action. A new proprietary herbomineral formulation was formulated with a combination of the herbal root extract 
ashwagandha and minerals viz. zinc, magnesium, and selenium. The aim of the study was to evaluate the immunomodulatory 
potential of Biofield Energy Healing (The Trivedi Effect
®
) on the test formulation in splenocytes. The test formulation was 
divided into two parts; one was the control without the Biofield Energy Treatment, while the other part was defined as the 
Biofield Energy Treated sample, which received the Biofield Energy Healing Treatment remotely by seven renowned Biofield 
Energy Healers. The MTT assay showed that the test formulation exhibited safe concentrations up to 1.053 µg/mL with cell 
viability ranging from 88.19% to 110.30% in the Biofield Energy Treated sample. The Biofield Energy Healing significantly 
enhanced the cell viability as compared with the untreated test formulation. The expression of TNF-α was significantly 
inhibited by 7.23% at 1.053 µg/mL in the Biofield Energy Treated test formulation compared with the vehicle control. The 
level of TNF-α was significantly decreased by 3.90%, 11.74%, 3.12%, and 9.17% at 0.001053, 0.01053, 0.1053 and 1.053 
µg/mL, respectively in the Biofield Energy Treated test formulation compared with the untreated test formulation. 
Additionally, the expression of IL-1β was significantly reduced by 28.98%, 51.23%, 53.06%, 48.98%, 55.71%, and 59.10% at 
0.00001053, 0.0001053, 0.001053, 0.01053, 0.1053, and 1.053 µg/mL, respectively in the Biofield Energy Treated test 
formulation compared with the vehicle control. Further, the Biofield Treated test formulation showed significant reduction of 
IL-1β by 35.07% (p≤0.05), 47.46% (p≤0.05), and 57.51% (p≤0.01) at 0.001053, 0.1053, and 1.053 µg/mL, respectively 
compared with the untreated test formulation. Similarly, the MIP-1α expression was inhibited by the Biofield Energy Treated 
formulation and showed immunosuppressive activity at 0.00001053, 0.0001053, 0.001053, and 0.01053 µg/mL by 19.38%, 
24.97%, 31.23%, and 25.41%, respectively compared with the vehicle control group. The Biofield Treated test formulation 
significantly (p<0.001) reduced the MIP-1α expression by 19.33%, 22.57%, and 30.50% at 0.0001053, 0.001053, and 0.01053 
µg/mL, respectively compared with the untreated test formulation. Overall, The Trivedi Effect
® 
- Biofield Energy Healing 
(TEBEH)
 
significantly down-regulated the pro-inflammatory cytokines and potentiated the immunosuppressive effect of the 
Biofield Energy Treated test formulation, which can be better utilized for organ transplants, autoimmune diseases, 
inflammatory disorders, anti-aging, stress management, overall health and quality of life, etc. 
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1. Introduction 
The therapeutic and healing properties of plant extracts 
have been recognized and utilized worldwide since ancient 
times. Plant products and their extracts are used in both 
allopathic health care as well as complementary and 
alternative health care in order to improve overall health and 
the immune system [1, 2]. However, much attention has been 
focused on discovering herbal products with 
immunomodulatory activity along with low toxicity and 
better bioavailability [3]. Many scientific studies have 
identified immunomodulatory properties within medicinal 
plants, which can be further potentiated with the addition of 
some minerals that regulate the immune cells. These types of 
formulations are commonly defined as herbomineral 
formulations and are the major target for pharmaceutical 
companies, commonly identified as phytopharmaceutical 
products or as dietary supplements. Based on the literature, a 
new proprietary herbomineral formulation was formulated 
with a combination of the herb ashwagandha (Withania 
somnifera) root extract and three minerals viz. zinc, 
magnesium, and selenium. All of the ingredients comprising 
the test formulation in this present study possess important 
activities such as immune-modulating, anti-inflammatory, 
antioxidant, anti-infective, and anti-viral properties [4-7]. 
According to scientific studies, ashwagandha effect on 
biological activity is mainly attributed to the presence of 
withanolides, and is used in many forms of complementary 
and alternative medicine therapies [8, 9]. Apart from it’s 
more commonly known attributes (such as antibacterial, 
immunomodulatory and antitumor effects), there has been 
many clinical and preclinical data that pay respect to its 
immunomodulatory impact [4, 10]. Minerals such as 
selenium, zinc, and magnesium play an important role in 
modulating the immune system because their synergistic 
impact has been well-defined [5]. Scientific research has 
documented that in the presence of minerals, herbal 
medicines have been found to exhibit a high level of 
phagocytic index and improved antibody titer [11]. These 
formulations can be used for better therapeutic effect in 
immune compromised patients affected with cardiovascular 
diseases, age and stress related diseases, cancer, and 
autoimmune disorders. Along with the herbomineral 
formulations, the Biofield Energy Healers in this study have 
used Energy Medicine (Biofield Energy Healing Treatment) 
as a complementary and alternative approach to study the 
impact of Biofield Energy Treatment on the herbomineral 
formulation for its immunomodulatory potential with respect 
to the pro-inflammatory cytokines in splenocyte cells isolated 
from mice. 
In recent years, several scientific reports along with 
clinical trials have demonstrated the beneficial effects of 
Biofield Energy Treatments, which have shown enhanced 
immune function in cases of cervical cancer patients with 
therapeutic touch [12] and massage therapy [13], etc. 
Biofield Energy Healing is a recognized complementary and 
alternative therapy that comes under the category of Energy 
Medicine. Complementary and Alternative Medicine (CAM) 
consist of therapies, medicines and practices that are 
recognized by The National Center for Complementary and 
Integrative Health (NCCIH) that include, but are not limited 
to, yoga, meditation, mindfulness, progressive relaxation, 
guided imagery, natural products, naturopathy, homeopathy, 
deep breathing, Tai Chi, Qi Gong, Reiki, healing touch, 
chiropractic/osteopathic manipulation, cranial sacral therapy, 
massage, special diets, acupuncture, acupressure, relaxation 
techniques, hypnotherapy, rolfing structural integration, 
movement therapy, pilates, traditional Chinese herbs and 
medicines, Ayurvedic medicine, essential oils, aromatherapy, 
and applied prayer (as is common in all religions like 
Buddhism, Christianity, Hinduism and Judaism). Human 
Biofield Energy has subtle energy that has the capacity to 
work in an effective manner [14]. Reports show that 
Complementary and Alternative Medicine (CAM) therapies 
have been practiced worldwide with reported clinical benefits 
in different health disease profiles [15]. This energy can be 
harnessed and transmitted by individuals into living and non-
living things via the process of Biofield Energy Healing. 
Biofield Energy Treatment (The Trivedi Effect
®
) has been 
extensively studied with significant outcomes in many 
scientific fields such as cancer research [16, 17], altering the 
antimicrobial sensitivity of pathogenic microbes in 
microbiology [18-21], genetics [22, 23], altering the 
structural, thermal, physical and chemical properties of 
pharmaceutical compounds [24-27], improving overall 
growth, productivity, quality and yield of plants in 
agricultural science [28-31], and in changing the structure of 
the atom in relation to various metals, ceramics, polymers 
and chemicals in materials science [32-35]. The authors of 
this study sought to evaluate the impact of Biofield Energy 
Treatment (The Trivedi Effect
®
) on the specified 
herbomineral formulation, which might improve the 
immunomodulatory function of mice splenocyte cells in an in 
vitro cellular model. 
2. Materials and Methods 
2.1. Chemicals and Reagents 
3-(4, 5-diamethyl-2-thiazolyl)-2, 5-diphenyl-2H-
tetrazolium) (MTT), lipopolysaccharide (LPS), L-glutamine, 
Roswell Park Memorial Institute (RPMI)-1640, penicillin, 4-
(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 
streptomycin, 2- mercaptoethanol were purchased from 
Sigma Chemical Corp. (St. Louis, MO), a subsidiary of 
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Sigma-Aldrich Corporation. ELISA (enzyme-link 
immunosorbent assay) kits for all cytokines such as tumor 
necrosis factor alpha (TNF-α), macrophage inflammatory 
protein-1α (MIP-1α), and interleukin-1 beta (IL-1β) were 
purchased from R&D Systems, USA. Fetal bovine serum 
(FBS) was procured from GIBCO, USA. Ashwagandha root 
extract powder was procured from Sanat Products Ltd., India. 
Zinc chloride and magnesium (II) gluconate hydrate were 
procured from Tokyo Chemical Industry Co., Ltd. (TCI), 
Japan. Sodium selenate was procured from Alfa Aesar, USA. 
Rapamycin, sodium bi-carbonate (NaHCO3), and ethylene 
diamine tetra acetic acid (EDTA) were procured from Sigma. 
All the other chemicals used in this experiment were of 
analytical grade and procured from local vendors in India. 
LPS was used as an immunostimulant. Concanavalin A and 
rapamycin were used as a reference standard (positive 
controls) in splenocyte culture. 
2.2. Test Formulation and Reference Standard 
The test herbomineral formulation contained a 
combination of four ingredients: ashwagandha root powder 
extract, zinc chloride, sodium selenite, and magnesium 
gluconate. LPS was used as an inflammatory stimulant, while 
Con-A and rapamycin were used as a reference standard 
(positive control) for immunostimulatory and 
immunosuppressive action, respectively in splenocytes assay. 
2.3. Experimental Animal 
C57BL/6 male mice (8 weeks old, 22 gm body weight) 
were purchased from Vivo Bio Tech Ltd., Hyderabad, India 
and acclimatized for one week prior to the experiments. The 
mice were maintained under controlled conditions with a 
temperature of 22 ± 3°C, humidity of 30% to 70% and a 12-
hour light/12-hour dark cycle and laboratory rodent diet and 
drinking tap water were provided ad libitum. All the 
procedures were in strict accordance with the Guide for the 
Care and Use of Laboratory Animals published by the US 
National Institutes of Health (NIH). The approval of the 
Institutional Animal Ethics Committee (IAEC) was obtained 
prior to carrying out the animal experiment. 
2.4. Biofield Energy Healing Strategies 
The herbomineral formulation was divided into two parts. 
One part was considered the control formulation and the 
other part was defined as the treated formulation. The treated 
test formulation was subjected to the Biofield Energy 
Healing (also known as The Trivedi Effect
®
) of seven 
Biofield Energy Healers and kept under strict, standard 
laboratory conditions. The Biofield Energy Treatment was 
provided for 5 minutes by the group of seven Biofield Energy 
Healers (The Trivedi Effect
®
), who were all remotely located 
in the U.S.A. The treated herbomineral formulation was 
located in the research laboratory of Dabur Research 
Foundation near New Delhi in Ghaziabad, India. None of the 
Biofield Energy Healers in this study visited the laboratory in 
person, nor had any contact with the herbomineral samples. 
Similarly, the control formulation was subjected to a “sham” 
healer under the same laboratory conditions for 5 minutes. 
The sham healer did not have any knowledge about the 
Biofield Energy Treatment. After that, the Biofield Energy 
Treated and the untreated samples were kept in similar sealed 
conditions until they were used for an estimation of various 
cytokines as per the study design. 
2.5. Experimental Design 
The experimental study was divided into 7 groups. Group 
1 comprised of the splenocyte cells without LPS and was 
denoted as the negative control. Group 2 served as a 
stimulant group that included cells with LPS. Group 3 
included the splenocyte cells with LPS along with the vehicle 
(0.005% DMSO) and was denoted as the vehicle control. 
Groups 4 and 5 were defined as the positive control, which 
included cells with Con-A (0.5 µg/mL) and rapamycin (1 nM 
and 10 nM), respectively. Groups 6 and 7 were denoted as 
the test item groups that included splenocyte cells with LPS 
along with the untreated and the Biofield Energy Treated test 
formulations, respectively, at 0.00001053 to 10.53 µg/mL. 
After 48 hours of incubation, supernatants were analyzed for 
the secreted levels of TNF-α, MIP-1α, and IL-1β using 
ELISA as per the manufacturer’s instructions. Concentrations 
were determined in triplicate wells of each sample. 
2.6. Isolation of Murine Splenocytes 
C57BL/6 male mice were sacrificed and the spleens were 
removed and ground by passing through a sterile plastic 
strainer under aseptic conditions. After that, the cells were 
centrifuged twice at 1000 g for 5 minutes. Erythrocytes were 
lysed by a lysis buffer (0.15 M NH4Cl, 0.01 M NaHCO3, and 
0.1 mM EDTA, pH 7.4) and then the cell pellets were washed 
twice with RPMI-1640 medium. Then the cells were 
resuspended in a fresh complete RPMI-1640 medium (RPMI 
1640 medium plus 10% FBS, 2 mM glutamine, streptomycin 
and 100 IU/mL of penicillin and 15 mM HEPES, and 50 mM 
2-mercaptoethanol). The cell counts were performed with the 
help of a hemocytometer and cell viability was determined 
using the trypan-blue dye exclusion technique and the results 
showed ≥80% of viable cells. The cells were cultured in 96-
well tissue culture plates with 0.2 x 10
6
 cells per well. They 
were incubated at 37°C in a humidified atmosphere 
containing 5% CO2 for the specified period [36]. 
2.7. Cell Culture and Test Formulation Treatment 
The splenocyte (0.2 x 10
6
 cells per well) cells were grown 
in 96-well culture plates using RPMI-1640 medium 
supplemented with 10% FBS, 100 µg/mL of streptomycin, 
and 100 units/mL of penicillin. The LPS (0.5 µg/mL) induced 
splenocyte cells cultures were grown for 48 hours at 37°C in 
a humidified CO2 incubator (5% CO2). The effect of 
cytotoxicity was determined by exposing cells to different 
concentrations of the test formulation in a RPMI-1640 
medium. Various concentrations of the test formulation from 
0.00001053 µg/mL to 10.53 µg/mL were used in splenocytes 
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culture. The respective vehicle control kept in the assay was 
DMSO. 
2.8. Cytotoxicity by MTT Assay 
The effects of the Biofield Energy Treated and untreated 
test formulations at the concentration range of 0.00001053 
µg/mL to 10.53 µg/mL were tested for cell viability using 3-
(4,5-dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide 
(MTT) assay. The number of viable cells was determined by 
the ability of the mitochondria to convert MTT to formazan 
dye. Splenocyte cells were cultured overnight in 96-well 
plates, at a density of 0.2 x 10
6
 cells per well. After treatment 
with the test formulation and incubation period, the medium 
was removed. 20 µL of 5 mg/mL MTT was then added to 
each well and incubated for 3 hours further at 37°C in a 
humidified 5% CO2 atmosphere. The cells were centrifuged 
and supernatants were removed. The cell pellet in each well 
was resuspended in 150 µL of DMSO to dissolve formazan 
crystals. The optical density of each well was read at 540 nm 
using a BioTek Reader (SIAFRT/Synergy HT multimode 
reader, US). 
The effect of the test formulation on the cell viability of 
splenocyte cells was determined as per the equation (1): 
%	Cell	viability = 100 −%	cytotoxicity            (1) 
Where; % cytotoxicity = [(O.D. of control cells – O.D. of 
the cells treated with the test formulation)/O.D. of control 
cells]*100. 
The concentrations that resulted in >75% viability were 
selected for subsequent cytokine estimation. 
2.9. Determination of Cytokines (TNF-α and IL-1β) and 
Chemokine (MIP-1α) Using ELISA 
The in vitro activities of the Biofield Energy Treated and 
untreated test formulations were estimated in the mice 
splenocytes for the production of TNF-α, MIP-1α, and IL-1β 
using enzyme-linked immunosorbent assay (ELISA). The 
ELISA plates were coated with an antibody in a coating 
buffer at the recommended concentration and kept overnight 
at 4°C. After washing with PBS-T (PBS with 0.05% Tween 
20), the plates were blocked with assay diluent for at least 2 
hours at room temperature. A total of 100 µL culture 
supernatant from different experimental samples and 
standards were incubated overnight at 4°C and, after three 
washes, biotinylated anti-mice cytokine (TNF-α, MIP-1α, 
and IL-1β) antibodies at the recommended concentrations 
were incubated for 1 hour at room temperature and the plate 
was incubated for 45 minutes at room temperature with 
gentle shaking. The plates were again washed 3 times and 
then 100 µL of horseradish per-oxidase (HRP)–streptavidin 
conjugate solution was added and the plate was incubated for 
45 minutes at room temperature with gentle shaking. Next, 
the plate wells were washed 3 times as per the previous 
methods and 100 µL of 3,3,5,5'-tetramethylbenzidine (TMB) 
one-step substrate reagent was added, followed by a 30-
minute incubation at room temperature in the dark. Further, 
50 µL of 0.2 mole/L sulphuric acid was added to each well to 
stop the reaction and the plates were read for absorbance at 
450 nm using a BioTek Reader (SIAFRT/Synergy HT 
multimode reader). Standards were run in parallel to the 
samples, and the concentrations were determined in 
triplicates for each sample [37]. 
2.10. Statistical Analysis 
Data were expressed as mean ± standard error of mean 
(SEM) and were subjected to one-way analysis of variance 
(ANOVA) followed by Dunnett’s test for multiple 
comparison and Student’s t-test for two groups comparison. 
Statistical significance was considered at p≤0.05. 
3. Results 
3.1. MTT Assay on Splenocyte Cells 
The effect of the Biofield Treated and untreated test 
formulations on the proliferation of mice splenocyte cells 
was examined after 48 hours through MTT cell viability 
assay. The effect of the test formulation on the viability of the 
splenocytes is shown in Figure 1. The results showed the % 
cell viability was altered after the Biofield Treatment in the 
tested concentration of the test formulation. The untreated, 
LPS, and Con-A group showed 100%, 171.7%, and 201.9% 
cell viability, respectively. The vehicle control group reported 
with 100% and the rapamycin group reported with 98.9% and 
89.9% at concentrations 1 and 10 nM, respectively. The 
increased cell viability with respect to the vehicle control 
might be due to proliferation in the cell culture. Con-A and 
rapamycin showed immunostimulatory and 
immunosuppressive action, respectively and used as the 
positive control in the experiment. Concentration ranges from 
0.00001053 to 10.53 µg/mL was selected for comparison of 
cell viability after adding the Biofield Treated and untreated 
test formulations to the splenocyte cells. The test formulation 
was found safe at concentrations up to 1.053 µg/mL with 
percentage viability ranging from 88.19% to 110.30%. The 
cell viability was greatly decreased at the concentration of 
10.53 µg/mL in both the Biofield Energy Treated (38.24%) 
and untreated formulations (26.12%), so this concentration 
was not selected for the estimation of cytokines. However, at 
three tested concentrations the Biofield Energy Treated test 
formulation showed increased cell viability, i.e. at 0.0001053, 
0.001053, and 0.01053 µg/mL by 10.09%, 8.90%, and 
10.30%, respectively as compared to the vehicle control 
group. The percentage of increased cell viability in the 
Biofield Energy Treated test formulation was 19.95% and 
46.40% at 0.1053 and 10.053 µg/mL, respectively as 
compared to the untreated test formulation. In addition, the 
cell viability was also increased at the concentration of 
0.0001053, 0.001053, 0.01053, and 1.053 µg/mL, while it 
decreased at 0.00001053 µg/mL in the Biofield Energy 
Treated test formulation as compared to the untreated test 
formulation. Overall, the results showed the cell viability was 
significantly altered after the Biofield Energy Treatment. 
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Figure 1. MTT assay in splenocyte cells after 48 hours of treatment with various concentrations of the test formulation in the presence of 0.5 µg/mL of LPS. 
The absorbance of the MTT formazan was determined at 540 nm in an ELISA reader. Cell viability was defined as the absorbance ratio (expressed as a 
percentage) of the test formulation treated cells relative to the untreated vehicle control group. 
3.2. Effect of the Test Formulation on the Expression of 
Pro-inflammatory Cytokines (TNF- α and IL-1β) and 
Chemokine (MIP-1α) in Splenocyte Cells 
Lymphocyte proliferation and the activation of natural 
killer (NK) cells are cytokine dependent [38]. The effect of 
the Biofield Treated herbomineral test formulation was 
observed on pro-inflammatory cytokines TNF-α, MIP-1α, 
and IL-1β. All play major roles in inflammation, immune 
modulation, and lymphocyte activation, so it might be 
expected that the herbomineral test formulation can modulate 
the expression and activation of cytokines. Therefore, the 
expression of TNF-α, MIP-1α and IL-1β at six concentrations 
was examined in the spleen cells. The effect of the test 
formulation on pro-inflammatory cytokines was estimated by 
incubating the formulation with various concentrations of the 
treated and untreated test formulations for 48 hours using 
ELISA assay. 
3.2.1. Assessment of TNF-α Expression 
The splenocyte cells were treated with the Biofield Energy 
Treated and untreated test formulations at non-cytotoxic 
concentrations (0.00001053 to 1.053 µg/mL) for 48 hours. 
The effect of the test formulation on TNF-α secretion in 
splenocyte cells is shown in Figure 2. The negative control 
(untreated cells), LPS, Con-A, and vehicle control group 
showed TNF-α values as 87.60, 504.65, 271.32, and 501.55 
pg/mL, respectively. The Biofield Energy Treated test 
formulation showed an increment of TNF-α expression by 
11.36%, 11.98%, and 10.28% at 0.00001053, 0.0001053, and 
0.1053 µg/mL, respectively as compared to the vehicle 
control group. However, at 1.053 µg/mL the expression of 
TNF-α was decreased by 7.23% as compared to the vehicle 
control group. Additionally, the untreated test formulation 
showed an increment of TNF-α expression by 10.82%, 
15.15%, and 13.83% at 0.001053, 0.01053, and 0.1053 
µg/mL, respectively as compared to the vehicle control 
group. However, in the rest of the tested concentrations 
(0.00001053, 0.0001053, and 1.053 µg/mL) the expression of 
TNF-α was minimally increased as compared to the vehicle 
control group. Overall, the Biofield Energy Treated test 
formulation showed the expression of TNF-α was 
significantly decreased by 3.90%, 11.74%, 3.12%, and 9.17% 
at 0.001053, 0.01053, 0.1053, and 1.053 µg/mL, respectively 
as compared to the untreated test formulation. The expression 
of TNF-α was increased in the Biofield Energy Treated test 
formulation by 4.88% and 7.65% at 0.00001053 and 
0.0001053 µg/mL, respectively as compared to the untreated 
test formulation (Figure 2). 
 
Figure 2. The effect of test formulation on cytokine TNF-α. For each concentration treatment, the level of TNF-α release was measured after 48 hours of 
treatment. The values are represented as mean ± SEM. 
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3.2.2. Estimation of IL-1β Expression 
The effects of the Biofield Energy Treated and untreated 
test formulations on IL-1β secretion in splenocyte cells are 
shown in Figure 3. Both the untreated and Biofield Energy 
Treated test formulations demonstrated inhibition of IL-1β 
as compared to the LPS induced group. However, the 
Biofield Energy Treated test formulation exhibited better 
suppression than the untreated test formulation at 3 
concentrations, which indicated that the Biofield Energy 
Healing enhanced the test formulation’s 
immunosuppressive properties. The IL-1β expression 
showed significant reduction by 28.98%, 51.23%, 53.06%, 
48.98%, 55.71%, and 59.10% at 0.00001053, 0.0001053, 
0.001053, 0.01053, 0.1053, and 1.053 µg/mL, respectively 
in the Biofield Energy Treated test formulation as compared 
to the vehicle control group. Further, the level of IL-1β was 
significantly reduced by 63.41%, 60.19%, 27.72%, 60.99%, 
15.70%, and 5.64% at 0.00001053, 0.0001053, 0.001053, 
0.01053, 0.1053, and 1.053 µg/mL, respectively in the 
untreated test formulation as compared to the vehicle 
control. At 0.001053, 0.1053, and 1.053 µg/mL the level of 
IL-1β was significantly suppressed by 35.07% (p≤0.05), 
47.46% (p≤0.05), and 57.51% (p≤0.01), respectively in the 
Biofield Energy Treated test formulation as compared to the 
untreated test formulation. However, at the other three 
concentrations (0.00001053, 0.0001053, and 0.01053 
µg/mL) the expression of IL-1β was increased to some 
extent as compared to the untreated test formulation. 
 
Figure 3. The effect of the LPS mediated production of IL-1β by the test formulation. For each concentration treatment, the level of IL-1β release was 
measured after 48 hours of treatment. The values are represented as mean ± SEM. *p≤0.05 and **p≤0.01 (as compared to the untreated test formulation). 
3.2.3. Estimation of MIP-1α Expression 
The effects of the Biofield Energy Treated and untreated test 
formulations on MIP-1α secretion in splenocyte cells are shown 
in Figure 4. The negative control (untreated cells), LPS, Con-A, 
and vehicle control group showed values of MIP-1α as 42.8 ± 
14, 598.6 ± 11.2, 285.5 ± 10.3, and 768.0 ± 10.2 pg/mL, 
respectively. Both the untreated and Biofield Energy Treated test 
formulations demonstrated inhibition of MIP-1-α as compared 
to the LPS stimulated group. Moreover, the Biofield Energy 
Treatment enhanced the immunosuppressive property of the test 
formulation at 3 concentrations. This indicated that the Biofield 
Energy Treated test formulation showed more inhibition than the 
untreated test formulation. The results showed the Biofield 
Energy Treated test formulation significantly reduced the MIP-
1α expression by 19.38%, 24.97%, 31.23%, and 25.41% at 
0.00001053, 0.0001053, 0.001053, and 0.01053 µg/mL, 
respectively as compared to the vehicle control group. However, 
the expression of MIP-1α was increased by 3.01% and 14.10% 
at 0.1053 and 1.053 µg/mL, respectively in the Biofield Energy 
Treated test formulation as compared to the vehicle control 
group. The level of MIP-1α was decreased by 16.80%, 7.10%, 
11.18%, 12.85%, and 9.60% at 0.00001053, 0.0001053, 
0.001053, 0.1053, and 1.053 µg/mL, respectively in the 
untreated test formulation, while the level of MIP-1α was 
increased at 0.01053 µg/mL as compared to the vehicle control 
group. Overall, there was a significant (p<0.001) down-
regulation of the MIP-1α expression at the three concentrations 
0.0001053, 0.001053, and 0.01053 µg/mL by 19.33%, 22.57%, 
and 30.50%, respectively in the Biofield Energy Treated test 
formulation as compared to the untreated test formulation. 
 
Figure 4. Dose-dependent inhibition of LPS mediated production of MIP-1α by the test formulation. For each concentration treatment, the level of MIP-1α 
release was measured after 48 hours of treatment. The values are represented as mean ± SEM. ***p<0.001 (as compared to the untreated test formulation). 
 American Journal of Bioscience and Bioengineering 2016; 4(5): 49-58 55 
 
 
4. Discussion 
Over the last decade, the use of herbomineral formulations 
and products to maintain, promote and improve overall 
health has gradually increased throughout the world. 
Furthermore, herbal extracts and plant products have the 
capacity to stimulate or modulate the immune system, which 
can be used to treat autoimmune diseases [39, 40]. The novel 
proprietary herbomineral test formulation used in this study 
consists of a mixture of the herbal root extract ashwagandha 
and the minerals zinc chloride, magnesium gluconate 
hydrate, and sodium selenate. Each of the individual 
components that comprise this formulation have already been 
proven to have immunomodulatory activity. Ashwagandha 
has been shown to inhibit TNF-α induced nuclear factor-
kappa B (NF-κB) activation in human myelomonoblastic 
leukemia cells in a study conducted by Singh and Aggrawal 
[41]. Selenium is an essential trace element that plays an 
important role in protecting cells from oxidative stress. As a 
dietary supplement, selenium may reduce the risk of 
cardiomyopathy, cancer, and immune disorders in humans 
[42, 43]. Zinc deficiency influences the generation of 
cytokines, including IL-1β, IL-2, IL-6, and TNF-α. Plasma 
cytokines also exhibit a dose-dependent response to zinc 
supplementation. The mechanism of action may reflect the 
ability of zinc to induce or inhibit the activation of NF-
κB. The wide involvement of zinc in the immune system [44] 
includes an ability to influence the production and signaling 
of numerous inflammatory cytokines in a variety of cell types 
[45, 46]. Magnesium sulfate reduced cytokine production in 
intrapartum women, as well as term and preterm neonates, 
demonstrating effectiveness in those at risk for inflammation 
associated adverse perinatal outcomes, whereby magnesium 
plays a critical regulatory role in NF-κB activation, cytokine 
production, and disease pathogenesis [47]. 
TNF-α is not only recognized as a circulating factor that 
causes necrosis of tumors, but is also identified as a key 
regulator of the inflammatory response [48]. Literature reports 
that TNF-α can interact with two different types of receptors, 
tumor necrosis factor receptor 1 and 2 (TNFR1 and TNFR2), 
which are differentially expressed in cells and tissues and 
initiate both distinct and overlapping signal transduction 
pathways [49]. These diverse signaling cascades lead to a 
range of cellular responses, which include cell death, survival, 
differentiation, proliferation, and migration [50]. In this 
experiment, it is assumed that the down-regulation of cellular 
response might be accelerated due to the Biofield Energy 
Healing Treatment to the test formulation. 
The cytokine cascade in pain and inflammatory processes 
is a tremendously complex system, involving glial, immune, 
and neuronal cell interactions [51]. The IL-1β is a pro-
inflammatory cytokine that has been implicated in pain, 
inflammation, and autoimmune conditions [52, 53]. 
Inflammation is the first response of the immune system to 
infection or irritation. It is caused by cytokines such as TNF-
α, IL-1, and IL-6 by eicosanoids such as prostaglandin E2 
(PGE2) [54]. Thus, inhibitors of these cytokines have been 
considered as candidates for anti-inflammatory drugs. The 
evaluation of immune cells, especially splenocyte cells, is 
always used to screen the potential immunomodulatory effect 
of a substance/product. These immune cells then migrate to 
the spleen, which is the secondary lymphoid tissue, and 
respond to antigens there. Therefore, the regulation of 
thymus and spleen cell proliferation, which is closely related 
to the maintenance of immune homeostasis, can be 
considered as important markers for immune response 
control. Lymphocytes/monocytes/macrophages are key 
mediators of inflammation and are widely distributed in the 
body [55]. Therefore, splenocyte cells represent appropriate 
model systems to study immune responses, and thus was 
utilized to investigate the anti-inflammatory effects of the 
newly developed proprietary herbomineral product in this 
present study. Based on the literature, it has been shown that 
human emotions like loneliness are directly correlated with 
the down-regulation of genes bearing anti-inflammatory 
response elements and the up-regulation of genes bearing 
response elements for pro-inflammatory NF-κB/Rel 
transcription factors [56]. Cole et al. (2007), reported that the 
human genome-wide transcriptional activity is altered in 
association with a social epidemiological risk factor like 
loneliness. An impaired transcription of glucocorticoid 
response genes and increased activity of pro-inflammatory 
transcription control pathways provide a functional genomic 
explanation for the elevated risk of inflammatory disease in 
individuals who experience chronically high levels of 
subjective social isolation [57]. 
In this study, the cytotoxic effect of the Biofield Energy 
Treated test formulation was screened by assessing the 
metabolic activity of immune cells through MTT assay. MTT 
assay is more rapid, less costly, less time-consuming, non-
radioactive and is proven to be accurate in determining the 
relation between the metabolic activity and cell growth [58]. 
This test is widely used in the in vitro evaluation of the 
toxicity of any test item [59]. The anti-inflammatory effects 
of both the Biofield Energy Treated and untreated test 
formulations were evaluated in mice splenocyte cells. The 
metabolic activity is evaluated by measuring the activity of 
the mitochondrial enzyme succinate dehydrogenase using the 
MTT test. The splenocytes (immune cells) were exposed at 
0.00001053 to 10.053 µg/mL of the test formulation for 48 
hours. The splenocyte cells showed cytotoxicity at 10.053 
µg/mL of the test formulation. The test formulation 
demonstrated the greatest potential for modulating the 
inflammatory response of splenocyte cells in vitro assay. 
There was a significant reduction of TNF-α, IL-1β, and MIP-
1α levels in the supernatants of most of the tested 
concentrations. Several cytokines are deeply associated with 
inflammatory diseases. In particular, TNF-α and IL-1β are 
prominent contributors to chronic inflammatory disorders. 
The TNF-α and IL-1β receptor antagonists have been 
clinically successful in improving the symptoms of RA 
patients [60]. Steroids such as prednisolone and 
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dexamethasone are known to reduce the production of these 
cytokines [61]. Our data suggest that the test formulation 
modulates the splenocytes’ function. The Biofield Energy 
Treated test formulation strongly inhibited the pro-
inflammatory cytokines TNF-α, MIP-1α, and IL-1β. 
Therefore, these results suggest that the test formulation may 
inhibit the inflammatory responsiveness of splenocytes by 
modulating the signal transduction pathways. This effect may 
be the result of specific inhibition of NF-κB, a transcription 
factor involved in the activation of many inflammatory 
mediator genes. Due to its immunomodulatory effects, the 
Biofield Energy Treated herbomineral test formulation may 
prove to be an innovative strategy to affect the immune 
system and to help combat various diseases. 
5. Conclusions 
The study results suggest that the Biofield Energy Treated 
test formulation showed better and significant inhibition of 
pro-inflammatory cytokines (TNF-α and IL-1β) and 
chemokine (MIP-1α) expression as compared to the untreated 
test formulation in splenocyte cells. The level of TNF-α was 
significantly decreased by 3.90%, 11.74%, 3.12%, and 9.17% 
at 0.001053, 0.01053, 0.1053, and 1.053 µg/mL, respectively 
in the Biofield Energy Treated test formulation as compared 
to the untreated test formulation. Moreover, the level of IL-
1β was significantly reduced by 35.07% (p≤0.05), 47.46% 
(p≤0.05), and 57.51% (p≤0.01) at 0.001053, 0.1053, and 
1.053 µg/mL, respectively in the Biofield Energy Treated test 
formulation as compared to the untreated test formulation. 
Even further, the expression of MIP-1α was significantly 
reduced by 19.33% (p<0.001), 22.57% (p<0.001), and 
30.50% (p<0.001) at 0.0001053, 0.001053, and 0.01053 
µg/mL, respectively in the Biofield Energy Treated test 
formulation as compared to the untreated test formulation. 
The Trivedi Effect
®
-Biofield Energy Healing (TEBEH) 
Treatment administered remotely by the seven Biofield 
Energy Healers enhanced the herbomineral test formulation’s 
anti-inflammatory and immunomodulatory properties without 
any adverse effect to the animals throughout the exposure 
period. Overall, the data showed that there was a significant 
reduction of all three pro-inflammatory mediators in the 
Biofield Energy Treated test formulation. Through the 
Biofield Energy Treatment, the test formulation’s anti-
inflammatory and immunomodulatory properties were 
enhanced. Thus, the Biofield Energy Treated test formulation 
may act as an effective anti-inflammatory and 
immunomodulatory product, and it can be used as a 
Complementary and Alternative Medicine (CAM) to prevent 
immune-mediated tissue damage in cases of organ transplants 
(for example kidney transplants, liver transplants and heart 
transplants), various autoimmune disorders such as Lupus, 
Systemic Lupus Erythematosus, Addison Disease, Celiac 
Disease (gluten-sensitive enteropathy), Dermatomyositis, 
Graves’ Disease, Hashimoto Thyroiditis, Multiple Sclerosis, 
Myasthenia Gravis, Pernicious Anemia, Aplastic Anemia, 
Reactive Arthritis, Rheumatoid Arthritis, Sjogren Syndrome, 
Type 1 Diabetes, Alopecia Areata, Crohn’s Disease, 
Fibromyalgia, Vitiligo, Psoriasis, Scleroderma, Chronic 
Fatigue Syndrome and Vasculitis, as well as inflammatory 
disorders such as Asthma, Irritable Bowel Syndrome (IBS), 
Ulcerative Colitis, Parkinson’s Disease, Alzheimer’s Disease, 
Atherosclerosis, Dermatitis, Diverticulitis, Hepatitis, and 
stress etc. Further, the Biofield Energy Healing Treated test 
formulation can also be used in the prevention of immune-
mediated tissue damage in cases of organ transplants (for 
example heart transplants, kidney transplants and liver 
transplants), for anti-aging, stress prevention and 
management, and in the improvement of overall health and 
quality of life. 
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